Problems posed by the therapeutic use of photosensitizers in dermatology

Three phototherapeutic regimens with photosensitization are now used in dermatology: PUVA (psoralen + UVA), TUV (crude coaltar + UV), PRT (phototherapy with hematoporphyrin derivative). The efficiency of PUVA and TUV is well known in several dermatoses. PRT is now being tested experimentally. For TUV, the lack of a standardized regimen does not allow a clear-cut evaluation of the therapy. For PUVA, late side-effects, particularly carcinogenicity have to be considered. To improve efficiency and minimize the side-effects of PUVA some procedures, such as association with retino?ds, pharmaco-kinetic studies for individual adaptation of the therapeutic regimen and the use of new less mutagenic psoralens are helpful. The persistent phototoxicity following treatments with hematoporphyrin derivative constitutes the major side-effect observed, for this phototherapy.     

Problems posed by natural environments for monitoring microorganisms

Microorganisms in natural environments have evolved to withstand fluctuations in physical and chemical conditions. This means that they often manifest very different biochemical and morphological features compared with those seen during laboratory culture. A major limitation in natural ecosystems is nutrient limitation under which microorganisms are exposed to starvation conditions and grow slowly or not at all. This review identifies the role of inimical processes on microbial properties such as the responses to starvation that may result in the adoption of viable but nonculturable (VBNC) states, discusses the problems that altered physiological states pose for detection and identification and highlights novel methods that have been developed to circumvent these difficulties. These factors dictate that to survive and respond to environmental stimuli, a cell must have evolved sophisticated programs of gene expression. These include the sigma factor rpoS that directs RNA polymerase to transcribe genes whose expression aids survival during severe nutrient limitation or cell-cell communication systems that promote a concerted population response termed quorum sensing.     

Problems posed by prenatal diagnosis of abdominal wall malformations

The authors present 6 observations of in utero detected abdominal wall defect : 2 laparoschisis and 4 omphaloceles. In three cases the diagnosis have been done prior week 20, by systematic AFP assay for amniocentesis performed for cytogenetic or metabolic reasons; the pregnancy was terminated. In three other cases, the pregnancy was complicated by hydramnios after week 30; amniocentesis for AFP and echography were performed to detect fetal malformations after associated with hydramnios. The detected abdominal wall anomaly was not alone: two fetus had an abnormal caryotype (trisomy 18), three other presented a polymalformative syndrome, a Beckwith-Wiedemann syndrome was discussed for the last child. The in utero diagnosis of omphalocele or laparoschisis implicates difficulties for genetic counselling, particularly if the diagnosis is done prior week 20. These anomalies can be treated with surgical management, but frequency of associated malformations must be underlined. it is important for genetic counselling to know the family history, the amniotic fluid cells caryotype, and an ultrasound scanning performed to reveal any other malformations.     

Detection of allergen specific immunoglobulins by microarrays coupled to microfluidics

Allergen microarrays are under development for a component‐resolved diagnosis of Type I (IgE‐mediated) allergies. Here we report an improved microarray coupled to microfluidics for the detection of allergen specific immunoglobulin E (IgE). The signal intensity for IgE detection in serum has been improved by using glass slides coated with a novel poly[DMA‐co‐NAS] brush copolymer which is able to immobilize allergens in their native conformation and by carrying out the incubation step in dynamic conditions. The assay, fully automated, was performed in a microcell, using a software‐controlled fluidic processor, to bring assay reagents on the surface of the array. Microfluidics turns the binding between serum immunoglobulins and immobilized allergens from a diffusion‐limited to a kinetic‐limited process by ensuring an efficient mixing of serum samples on the surface of the microarray. As a result of this, the binding of high affinity IgE antibodies is enhanced whereas that of low affinity IgG antibodies, which are present at higher concentration, is impaired paving the way to more accurate and sensitive results.     

The production of specific immunoenzyme conjugates to human immunoglobulins by the glutaraldehyde method]

The results of studies aimed at obtaining class-specific conjugates to human immunoglobulins to be used in the enzyme immunoassay (EIA) are presented. At the first stage of the studies purified IgA, IgM and IgG preparations were obtained. These preparations were used for obtaining immunologically active immunosorbents on the basis of bromocyanic Sepharose. Specific antibodies to human IgA, IgM and IgG were isolated from animal sera by the method of affinity chromatography. These antibodies were conjugated with peroxidase by the glutaraldehyde method. The specific activity of the conjugates were determined in EIA. The results thus obtained revealed that all preparations exhibited high specific activity and gave no cross reactions with immunoglobulins of other classes.     

Imidoester iodination of immunoglobulins to high specific activity

Immunoglobulins were labeled via the di-iodinated derivative of methyl-para-hydroxybenzimidate (1). Radioactive iodine could be incorporated at high specific activities without alteration of the overall positive charge or significant inactivation of the antibody activity.     

Facing the global challenges posed by biological weapons

This review article examines the growing concern about the threat posed by the use of biological weapons by States or terrorist groups. The article analyzes the nature of the perceived risk from bioweapons, the historical attempts to control them, and the emerging policy and legal framework designed to deal with the bioweapon threat.     

Delipidation of a beta-adrenergic receptor preparation and reconstitution by specific lipids

The role of lipids in the function of membrane receptors for hormones and neurotransmitters is still obscure. To gain information on this subject, a delipidated receptor preparation was developed. The beta-adrenergic receptor from turkey erythrocyte membranes was solubilized in deoxycholate and was freed extensively of phospholipids and of cholesterol by gel filtration. The delipidated preparation, after removal of the detergent, showed little, if any, ligand binding to the receptor as measured with the beta-adrenergic antagonist [125I] iodocyanopindolol. Readdition of soybean lipids restored specific radioligand binding. The lipid reconstituted receptor demonstrated agonist and antagonist binding affinities which were not very different from those of the native receptor. The receptor also retained its ability to function, as demonstrated by transfer to a foreign adenylate cyclase system. The delipidated receptor preparation lent itself conveniently to study the requirement for specific lipids in restoration of agonist and antagonist binding. Phosphatidylethanolamine restored maximal binding. Acidic phospholipids and sphingomyelin were inefficient in reconstitution of the receptor. The effect of cholesterol addition was also investigated. Binding was dramatically increased when a cholesterol ester was added in mixture with the acidic phospholipids, cardiolipin or phosphatidylinositol. Further studies unexpectedly revealed that reconstitution of the delipidated receptor is not exclusively dependent on the addition of a phospholipid; a mixture of 1-monooleylglycerol with cholesteryl hemisuccinate restored binding as efficiently as phosphatidylethanolamine. The presently described preparation should be useful in elucidating the part played by lipids in the action of the receptor in the adenylate cyclase system.